Xu, C.; He, L.; Zhang, J.; Xu, L.; Dong, J.; Liao, L.
The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis. Metabolites 2022, 12, 979.
https://doi.org/10.3390/metabo12100979
AMA Style
Xu C, He L, Zhang J, Xu L, Dong J, Liao L.
The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis. Metabolites. 2022; 12(10):979.
https://doi.org/10.3390/metabo12100979
Chicago/Turabian Style
Xu, Chunmei, Liping He, Jing Zhang, Lusi Xu, Jianjun Dong, and Lin Liao.
2022. "The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis" Metabolites 12, no. 10: 979.
https://doi.org/10.3390/metabo12100979
APA Style
Xu, C., He, L., Zhang, J., Xu, L., Dong, J., & Liao, L.
(2022). The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis. Metabolites, 12(10), 979.
https://doi.org/10.3390/metabo12100979